title: Do patients with obstructive sleep apnoea deserve new dedicated antihypertensive strategies?
authors.affiliation: HP2 Laboratory, Inserm, Univ. Grenoble Alpes, Grenoble, France.|Pôle Thorax et Vaisseaux, Grenoble Alpes University Hospital, Grenoble, France.
authors.forename: Renaud
authors.identifier: 0000-0003-1128-6529
authors.initials: R
authors.lastname: Tamisier
authors.affiliation: HP2 Laboratory, Inserm, Univ. Grenoble Alpes, Grenoble, France.|Pôle Thorax et Vaisseaux, Grenoble Alpes University Hospital, Grenoble, France.
authors.forename: Patrick
authors.initials: P
authors.lastname: Lévy
authors.affiliation: HP2 Laboratory, Inserm, Univ. Grenoble Alpes, Grenoble, France.|Pôle Thorax et Vaisseaux, Grenoble Alpes University Hospital, Grenoble, France.
authors.forename: Jean-Louis
authors.initials: JL
authors.lastname: Pépin
mesh_terms: D000959:Antihypertensive Agents; D006801:Humans; D020181:Sleep Apnea, Obstructive
chemical_list: D000959:Antihypertensive Agents
keywords: Sleep apnoea